Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin F Gibson

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Plos One|July 21, 2015
Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary FibrosisMichael Donahoe, Vincent G Valentine, Nydia Chien, et al.
Plos One|June 18, 2015
Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary FibrosisMichael Donahoe, Vincent G Valentine, Nydia Chien, et al.
Journal of Palliative Medicine|October 19, 2016
Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care UnitZhan Liang, Leslie A Hoffman, Mehdi Nouraie, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2022
Randomized Phase IIa Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Antje Prasse, et al.
Chest|September 5, 2014
Palliative care and location of death in decedents with idiopathic pulmonary fibrosisKathleen O Lindell, Zhan Liang, Leslie A Hoffman, et al.
The European Respiratory Journal|January 24, 2015
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosisDavid S Wilkes, Terrence Chew, Kevin R Flaherty, et al.
The Journal of Biological Chemistry|June 4, 2015
Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 LigaseSeungHye Han, Travis B Lear, Jacob A Jerome, et al.
The European Respiratory Journal|November 2, 2013
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progressionJason W Chien, Thomas J Richards, Kevin F Gibson, et al.
Plos One|December 31, 2013
Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosisLouis J Vuga, Jadranka Milosevic, Kusum Pandit, et al.
Chest|November 9, 2024
Trends in All-Cause Mortality Among US Veterans With Sarcoidosis, 2004-2022Mohamed I Seedahmed, Mohamed T Albirair, Aaron D Baugh, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Plos One|July 21, 2015
Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary FibrosisMichael Donahoe, Vincent G Valentine, Nydia Chien, et al.
Plos One|June 18, 2015
Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary FibrosisMichael Donahoe, Vincent G Valentine, Nydia Chien, et al.
Journal of Palliative Medicine|October 19, 2016
Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care UnitZhan Liang, Leslie A Hoffman, Mehdi Nouraie, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2022
Randomized Phase IIa Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Antje Prasse, et al.
Chest|September 5, 2014
Palliative care and location of death in decedents with idiopathic pulmonary fibrosisKathleen O Lindell, Zhan Liang, Leslie A Hoffman, et al.
The European Respiratory Journal|January 24, 2015
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosisDavid S Wilkes, Terrence Chew, Kevin R Flaherty, et al.
The Journal of Biological Chemistry|June 4, 2015
Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 LigaseSeungHye Han, Travis B Lear, Jacob A Jerome, et al.
The European Respiratory Journal|November 2, 2013
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progressionJason W Chien, Thomas J Richards, Kevin F Gibson, et al.
Plos One|December 31, 2013
Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosisLouis J Vuga, Jadranka Milosevic, Kusum Pandit, et al.
Chest|November 9, 2024
Trends in All-Cause Mortality Among US Veterans With Sarcoidosis, 2004-2022Mohamed I Seedahmed, Mohamed T Albirair, Aaron D Baugh, et al.
Pageof 8